Neuronetics STIM 深 滬
等待開盤 06-26 09:30:00 美东时间
1.28
+0.020
+1.59%
華盛通- 最 高1.315
- 今 開1.28
- 成交量 31.62万股
- 最 低 1.255
- 昨 收 1.26
- 總市值 8.91万
- 52周最高 4.8495
- 市盈率 靜 --
- 換手率 0.45%
- 52周最低 0.80
- 委 比 8.15%
- 總股本 6.96万
- 歷史最高 39.39
- 量 比 0.55
- 振 幅 4.76%
- 歷史最低 0.52
- 每 手 1
- 風險率 0.98%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Neuronetics Promotes Cory Anderson to Lead Greenbrook Unit
An announcement from Neuronetics ( ($STIM) ) is now available. On June 16, 2026...
06-24 06:01
Neuronetics, Inc.2026年Q1营收3450万美元 亏损收窄
经济观察网 Neuronetics, Inc.公布2026年第一季度业绩，营收同比增长，亏损有所收窄，同时披露成本优化计划与全年业绩指引。 业绩经营情况： 公司...
05-28 23:08
Neuronetics shifts interim finance officer Brown to $26,000 monthly consulting fee
Neuronetics shifts interim finance officer Brown to $26,000 monthly consulting fee Neuronetics revised the consulting compensation for interim principal financial and accounting officer Francis X. Brown III to USD 26,000 per month, replacing a fixed hourly rate. The amended and restated consulting a
05-22 19:33
Neuronetics Collaborates With ANT Neuro To Expand NeuroStar Advanced Therapy System
Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of
05-14 20:42
Neuronetics shares are trading higher after the company reported better-than-expected Q1 financial results and reaffirmed its FY2026 sales guidance.
Neuronetics shares are trading higher after the company reported better-than-ex...
05-05 23:26
Full Transcript: Neuronetics Q1 2026 Earnings Call
Neuronetics (NASDAQ:STIM) held its first-quarter earnings conference call on Tu...
05-05 21:25
Neuronetics Affirms FY2026 Sales Guidance of $160.000M-$166.000M vs $162.467M Est
Business OutlookFor the second quarter of 2026, the Company expects total revenue growth in the mid-single digits.For the full year 2026, Neuronetics continues to expect:Total revenue between $160 million and $166
05-05 19:54
Neuronetics Q1 EPS $(0.16) Beats $(0.17) Estimate, Sales $34.454M Beat $34.183M Estimate
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.17) by 5.88 percent. This is a 23.81 percent increase over losses of $(0.21) per share from the
05-05 19:53
BRIEF-Neuronetics Q1 Gross Margin 46.9%
BRIEF-Neuronetics Q1 Gross Margin 46.9% May 05 (Reuters) - Neuronetics Q1 operating expenses USD 25.1 million. Q1 EPS USD -0.16
05-05 19:50
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
